Surrozen Stock (NASDAQ: SRZN) stock price, news, charts, stock research, profile.
Open | $9.160 |
Close | $8.970 |
Volume / Avg. | 8.980K / 16.791K |
Day Range | 8.590 - 9.837 |
52 Wk Range | 4.500 - 16.190 |
Market Cap | $30.069M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 0.31% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Surrozen (NASDAQ: SRZN) through any online brokerage.
Other companies in Surrozen’s space includes: Serina Therapeutics (AMEX:SER), Vaxxinity (NASDAQ:VAXX), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Surrozen (NASDAQ: SRZN) was reported by JP Morgan on Tuesday, November 29, 2022. The analyst firm set a price target for 0.00 expecting SRZN to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Surrozen (NASDAQ: SRZN) is $9.4 last updated April 17, 2024 at 5:47 PM EDT.
There are no upcoming dividends for Surrozen.
Surrozen’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Surrozen.
Surrozen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.